Australia markets closed

RxSight, Inc. (RXST)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
56.17+0.40 (+0.72%)
At close: 04:00PM EDT
57.16 +0.99 (+1.76%)
Pre-market: 07:30AM EDT

RxSight, Inc.

100 Columbia
Aliso Viejo, CA 92656
United States
949 521 7830
https://www.rxsight.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees374

Key executives

NameTitlePayExercisedYear born
Dr. Ronald M. Kurtz M.D.President, CEO & Director1.21MN/A1963
Ms. Shelley B. ThunenChief Financial Officer762.22kN/A1954
Dr. Ilya Goldshleger Ph.D.Chief Operating Officer761.46kN/A1975
Mr. Eric J. WeinbergChief Commercial Officer762.74kN/A1961
Ms. Rebecca WillistonVice President of Accounting & FinanceN/AN/AN/A
Mr. Matt Haller Ph.D.Chief Technology OfficerN/AN/AN/A
Mr. Oliver MoravcevicVice President of Investor RelationsN/AN/AN/A
Mr. Roy FreemanVice President of MarketingN/AN/AN/A
Ms. Caroline VaughnVice President of Human ResourcesN/AN/AN/A
Mr. Scott GainesSenior VP of Commercial Operations & Business ProcessN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Corporate governance

RxSight, Inc.’s ISS governance QualityScore as of 1 June 2024 is 6. The pillar scores are Audit: 4; Board: 4; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.